The 63rd American Society of Hematology (ASH) provides an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates on the most critical topics in hematology. Evidera will be presenting a poster at the meeting hosted in both Atlanta, Georgia and virtually titled, “Considerations for Optimal Administration of Chimeric Antigen Receptor (CAR) T-Cell Therapy Programs: A Multi-Stakeholder Qualitative Analysis.” Authors include: Hoda D, Faber EA, Deol A, Hunter B, Crivera C, Riccobono C, Garrett A, Jackson CC, Fowler J, Berger A, Lorden AL, Stewart R
